1. Home
  2. BIO vs DOCU Comparison

BIO vs DOCU Comparison

Compare BIO & DOCU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$295.88

Market Cap

8.0B

Sector

Industrials

ML Signal

HOLD

Logo DocuSign Inc.

DOCU

DocuSign Inc.

HOLD

Current Price

$46.49

Market Cap

9.6B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
BIO
DOCU
Founded
1952
2003
Country
United States
United States
Employees
7450
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
EDP Services
Sector
Industrials
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
8.0B
9.6B
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
BIO
DOCU
Price
$295.88
$46.49
Analyst Decision
Buy
Hold
Analyst Count
4
17
Target Price
$339.75
$63.33
AVG Volume (30 Days)
318.0K
4.5M
Earning Date
04-30-2026
06-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.40
Revenue
N/A
$3,219,500,000.00
Revenue This Year
$2.74
$10.58
Revenue Next Year
$3.20
$7.33
P/E Ratio
$9.72
$114.43
Revenue Growth
N/A
8.16
52 Week Low
$236.73
$40.16
52 Week High
$343.12
$86.65

Technical Indicators

Market Signals
Indicator
BIO
DOCU
Relative Strength Index (RSI) 53.91 52.47
Support Level $293.88 $44.43
Resistance Level $312.51 $50.24
Average True Range (ATR) 9.55 1.92
MACD 0.52 0.36
Stochastic Oscillator 72.26 95.26

Price Performance

Historical Comparison
BIO
DOCU

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About DOCU DocuSign Inc.

Docusign offers Agreement Cloud, a broad cloud-based software suite that enables users to automate the agreement process and provide legally binding e-signatures from nearly any device. The company was founded in 2003 and completed its initial public offering in 2018.

Share on Social Networks: